Royal Bank of Canada Reiterates Sell Rating for United-Guardian (NASDAQ:UG)

United-Guardian (NASDAQ:UG)‘s stock had its “sell” rating restated by equities research analysts at Royal Bank of Canada in a research note issued to investors on Tuesday, Stock Target Advisor reports. They currently have a $18.00 price objective on the stock. Royal Bank of Canada’s price objective would indicate a potential downside of 6.49% from the company’s previous close.

Several other research analysts have also recently issued reports on the company. Credit Suisse Group reaffirmed a “neutral” rating and issued a $27.50 price target on shares of United-Guardian in a report on Thursday, October 24th. ValuEngine cut United-Guardian from a “buy” rating to a “hold” rating in a report on Friday, August 2nd. Kepler Capital Markets reaffirmed a “buy” rating and issued a $30.00 price target on shares of United-Guardian in a report on Saturday, November 2nd. Sanford C. Bernstein reaffirmed a “buy” rating and issued a $30.00 price target on shares of United-Guardian in a report on Wednesday, October 23rd. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $28.00 price target on shares of United-Guardian in a report on Wednesday, October 30th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $26.95.

Shares of NASDAQ:UG opened at $19.25 on Tuesday. United-Guardian has a 12 month low of $16.54 and a 12 month high of $20.81. The stock has a market cap of $90.14 million, a price-to-earnings ratio of 21.33 and a beta of -0.29. The stock’s 50 day moving average price is $18.76 and its 200 day moving average price is $19.25.

United-Guardian (NASDAQ:UG) last posted its quarterly earnings results on Friday, August 9th. The company reported $0.23 earnings per share (EPS) for the quarter. The company had revenue of $3.28 million for the quarter. United-Guardian had a return on equity of 36.04% and a net margin of 32.69%.

Large investors have recently made changes to their positions in the business. BlackRock Inc. raised its stake in United-Guardian by 8.7% during the 2nd quarter. BlackRock Inc. now owns 25,397 shares of the company’s stock valued at $478,000 after purchasing an additional 2,039 shares during the period. Renaissance Technologies LLC raised its stake in United-Guardian by 2.3% during the 2nd quarter. Renaissance Technologies LLC now owns 262,800 shares of the company’s stock valued at $4,941,000 after purchasing an additional 5,800 shares during the period. Finally, Morgan Stanley raised its stake in United-Guardian by 216.1% during the 2nd quarter. Morgan Stanley now owns 9,707 shares of the company’s stock valued at $182,000 after purchasing an additional 6,636 shares during the period. 26.15% of the stock is currently owned by institutional investors.

United-Guardian Company Profile

United-Guardian, Inc manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base.

Read More: What is basic economics?

Stock Target Advisor

Analyst Recommendations for United-Guardian (NASDAQ:UG)

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.